MedPath

Universal Skincare Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Straberi Epistamp Needling Treatment For Skin Rejuvenation

Not Applicable
Completed
Conditions
Wrinkle
Elastic Skin
Collagen Degeneration
First Posted Date
2021-02-08
Last Posted Date
2023-12-06
Lead Sponsor
Universal Skincare Institute
Target Recruit Count
30
Registration Number
NCT04742803
Locations
🇺🇸

Lavish, New York, New York, United States

Straberi Microneedling For Atrophic Acne

Not Applicable
Completed
Conditions
Atrophic Acne Scar
First Posted Date
2021-02-05
Last Posted Date
2023-12-06
Lead Sponsor
Universal Skincare Institute
Target Recruit Count
25
Registration Number
NCT04740268
Locations
🇺🇸

Lavish Beauty, New York, New York, United States

Straberi Epistamp Device for Postinflammatory Hyperpigmentation

Not Applicable
Completed
Conditions
Postinflammatory Hyperpigmentation
First Posted Date
2021-02-05
Last Posted Date
2023-12-06
Lead Sponsor
Universal Skincare Institute
Target Recruit Count
30
Registration Number
NCT04740255
Locations
🇺🇸

Lavish, New York, New York, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.